Algert Global’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Algert Global’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,930	Closed	-$551K	–	1365
2021 Q4	$551K	Sell	5,930 -6,510	-52%	-$429K	0.07%	506
2021 Q3	$741K	Buy	12,440 +1,213	+11%	+$71.6K	0.1%	373
2021 Q2	$766K	Buy	+11,227	New	+$732K	0.26%	131

Algert Global's ARNA Position: Q1 2022 in Review

Algert Global sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5,930 shares — an estimated $551K sold.

Algert Global first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $766K in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Algert Global reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Algert Global sold 5,930 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $551K.
Algert Global first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
Algert Global's Arena Pharmaceuticals Inc position peaked at $766K in Q2 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Algert Global's 13F filing for Q1 2022, filed 16 May 2022.